Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Eurofins Scientific stock

ERF.PA
FR0014000MR3
A2QJCT

Price

45.44
Today +/-
-0.73
Today %
-1.59 %
P

Eurofins Scientific stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Eurofins Scientific stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Eurofins Scientific stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Eurofins Scientific stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Eurofins Scientific's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Eurofins Scientific Stock Price History

DateEurofins Scientific Price
11/15/202445.44 undefined
11/14/202446.17 undefined
11/13/202444.97 undefined
11/12/202445.40 undefined
11/11/202446.15 undefined
11/8/202445.58 undefined
11/7/202445.50 undefined
11/6/202445.23 undefined
11/5/202445.81 undefined
11/4/202445.93 undefined
11/1/202445.88 undefined
10/31/202445.18 undefined
10/30/202444.90 undefined
10/29/202446.38 undefined
10/28/202447.00 undefined
10/25/202446.73 undefined
10/24/202446.80 undefined
10/23/202446.87 undefined
10/22/202447.56 undefined
10/21/202453.76 undefined
10/18/202456.42 undefined

Eurofins Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Eurofins Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eurofins Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eurofins Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Eurofins Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Eurofins Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Eurofins Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eurofins Scientific’s growth potential.

Eurofins Scientific Revenue, EBIT and net profit per share

DateEurofins Scientific RevenueEurofins Scientific EBITEurofins Scientific Net Income
2028e10.05 B undefined1.41 B undefined1.06 B undefined
2027e9.03 B undefined1.3 B undefined918.6 M undefined
2026e8.1 B undefined1.17 B undefined757.36 M undefined
2025e7.55 B undefined1.05 B undefined671.75 M undefined
2024e7.05 B undefined921.84 M undefined593.79 M undefined
20236.51 B undefined841.7 M undefined256.5 M undefined
20226.71 B undefined1.04 B undefined580.9 M undefined
20216.72 B undefined1.47 B undefined748.5 M undefined
20205.44 B undefined1.02 B undefined505.3 M undefined
20194.56 B undefined573.5 M undefined145.5 M undefined
20183.78 B undefined520.76 M undefined175.32 M undefined
20172.97 B undefined399.56 M undefined179.44 M undefined
20162.54 B undefined357.62 M undefined138.37 M undefined
20151.95 B undefined264.33 M undefined56.36 M undefined
20141.41 B undefined189.88 M undefined77.98 M undefined
20131.23 B undefined161.9 M undefined53.13 M undefined
20121.04 B undefined131.12 M undefined53.8 M undefined
2011828.93 M undefined109.45 M undefined43.82 M undefined
2010680.33 M undefined63.05 M undefined23.4 M undefined
2009640.07 M undefined41.51 M undefined-11.23 M undefined
2008632.76 M undefined48.1 M undefined17.71 M undefined
2007491.77 M undefined39.07 M undefined17.64 M undefined
2006370.2 M undefined38.32 M undefined17.51 M undefined
2005233.79 M undefined29.83 M undefined12.39 M undefined
2004175.96 M undefined15 M undefined7.85 M undefined

Eurofins Scientific Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
00.010.020.030.050.130.160.170.180.230.370.490.630.640.680.831.041.231.411.952.542.973.784.565.446.726.716.517.057.558.19.0310.05
-100.00150.00113.3359.38149.0227.564.323.5533.1458.8032.7028.721.276.2521.7625.9717.4515.1038.3030.0517.1527.2620.6619.2023.52-0.07-2.958.217.157.2211.4511.31
100.00100.0060.0062.5062.7561.4259.8861.5464.5764.8160.8160.4960.2860.7862.6518.2416.8717.8818.4418.4618.8918.7119.0220.3925.9728.3022.5420.9219.3418.0516.8315.1013.57
00.010.010.020.030.080.10.10.110.150.230.30.380.390.430.150.180.220.260.360.480.560.720.931.411.91.511.3600000
00000-0000.010.010.020.020.02-0.010.020.040.050.050.080.060.140.180.180.150.510.750.580.260.590.670.760.921.06
--------600.0071.4341.67---164.71-309.0986.9623.26-45.28-27.27146.4329.71-2.23-17.14248.2848.12-22.46-55.86131.6413.1512.8221.2715.80
---------------------------------
---------------------------------
105.93105.93116.1116.1122.22131.27136.72136.82141.24143.91149.39150.77151.78141.83148.59156.84158.06159.94160.6162.66169.57179.98183.01186195.9200.6199197.900000
---------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Eurofins Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Eurofins Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
00.010.010.010.040.010.020.020.040.040.080.060.130.050.110.180.130.30.220.790.830.820.510.30.910.520.491.22
0000.010.010.030.040.030.030.060.090.120.150.140.150.20.230.260.310.420.50.670.8111.191.391.341.38
0.570.670.961.181.214.254.865.654.696.039.423.9318.1124.5428.143.4443.1659.365792.17107.77159.97236.09183.8195.6191.8255.6236.5
0.10.10.550.91.924.646.9877.119.4317.0524.767.657.778.399.9513.8620.1424.6237.5239.5551.8166.3779.3157154.2145.6139
0.0100.161.152.32.931.261.81.772.530.4104.875.795.677.119.610.6315.1279.19107.99127.6289.4642.859.768.583.889.2
00.010.010.020.060.050.070.070.080.120.20.230.310.230.30.440.430.640.621.421.581.831.711.62.522.322.313.07
0000.010.010.030.040.040.040.050.070.110.130.140.140.160.210.250.320.430.510.691.021.591.571.832.172.3
0.010.013.560.1212.760.692.922.044.197.518.69.137.387.759.3911.4817.6821.426.154737.5349.5872.6354.556.681.783.683.6
0000000000000000000000000000
00.0300.050.41.732.312.272.314.0613.4623.1426.5429.9430.2159.2469.0386.38193.53351.47383.21735.12946.92918.2825.1895.7919.1796
000.010.010.020.050.050.050.060.090.160.230.240.240.250.380.40.460.681.411.582.513.423.613.524.124.524.55
00000032.281.562.7710.6113.1716.7115.6417.2819.4628.6337.1929.6637.6237.829.6944.174476.690.975.793.8
000.020.020.050.090.10.10.110.150.260.380.420.430.440.630.730.851.252.282.554.015.56.226.067.017.777.82
0.010.010.030.040.10.140.160.170.190.270.460.610.730.660.741.071.161.51.873.74.135.837.217.828.589.3310.0810.89
                                                       
11.521.671.831.311.321.321.321.361.381.391.41.421.421.431.441.491.511.521.541.691.761.781.81.91.91.91.9
0010.0316.6651.9952.0652.1552.256.950000000000000000000
00.010000000.010.080.10.110.110.10.120.150.210.250.330.270.91.461.611.72.853.543.933.99
0-0-0000-0-0-0-000.10.10.10.10.160.160.130.330.680.720.981.051.140.841.110.871.14
0000000000000000000000000000
00.010.010.020.060.050.050.050.070.080.10.210.210.20.220.320.370.390.660.961.632.442.672.843.694.654.85.13
0.590.891.52.045.8713.5715.7814.0416.0623.6836.1755.2356.850.5654.9375.0177.8100.95127.14197.02230.12206.14231.94231.5278.8322.9347.4339.2
00000000000060.0363.5972.1193.77107.44133.78162.76242.39278.76435.63560.8623.7796.6874.6843.7320.2
1.30.872.75.3517.2723.5725.9131.7325.433770.21107.5946.7740.9543.5280.1779.6686.7589.43122.09157.61255.89266.84271.6383.4404.4367.3861.2
0000.5100.090.450.693.775.881.43.53.812.1111.195.7412.063.991.532.7-1.22234.33372.24319.516.980.378.40.2
1.460.841.332.093.197.3212.0310.9915.0723.4420.7614.5522.1220.6326.8828.2740.0213.2470.65210.7844.73319.918.83135.3220.7173.5135.4600.9
000.010.010.030.040.050.060.060.090.130.180.190.180.210.280.320.340.450.770.711.451.451.581.71.861.772.12
000.010.010.010.030.040.040.040.070.180.160.260.220.240.40.380.670.641.51.341.662.773.092.922.53.113.33
0000000.841.060.360.963.097.697.787.1311.2920.9325.3828.9742.2794.183.91126.35138.56124.5115.3123.6133.6110
0.330.050.020.739.1110.4812.0718.0318.6220.6348.3152.6153.7855.9646.9249.7163.1667.7277.12253.9238.42109.99127.88132130.2175.5214.9193.9
000.010.010.020.040.050.060.060.090.230.220.330.280.30.470.470.760.761.841.661.93.033.343.162.83.463.63
000.010.020.050.090.110.110.120.180.360.40.510.460.510.750.791.11.212.622.373.354.484.934.864.665.235.75
0.010.010.030.040.10.140.160.170.190.260.460.610.730.650.731.071.161.491.873.5845.797.157.768.559.3110.0310.88
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Eurofins Scientific provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Eurofins Scientific's financial health and stability.

Assets

Eurofins Scientific's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Eurofins Scientific must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Eurofins Scientific after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Eurofins Scientific's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000-0000.010.020.030.030.03-00.040.070.080.090.10.130.240.250.290.270.691.060.780.42
000131012111113192636464248546681111141216301495528542608664
0000000-100000000000000000000
00-1,000-2,0001,000-2,000-1,000-2,000-5,000-13,000-15,000-21,000-12,000-11,000-7,000-21,000-23,000-16,000-15,000-45,000-79,000-90,000-88,000-159,000-142,000-315,000-264,000-204,000
0000000153048311413213044936728416914222712134
0000000024810121411121921303055455993671684982
0001000035717119915123032427379679594296296139
000000.010.010.010.020.030.040.040.060.060.080.110.130.170.210.290.370.410.540.681.221.511.141.02
00-10-5-4-12-10-12-11-19-25-48-54-45-40-53-71-99-134-169-199-245-364-425-355-506-660-550
00-14-5-14-45-17-9-19-57-82-108-81-62-48-204-144-189-422-863-391-1,747-1,557-540-525-1,021-855-681
00-30-10-32-63-7-37-56-59-26-17-7-150-72-89-287-694-192-1,501-1,193-115-169-514-195-131
0000000000000000000000000000
000021112-4123397-35111-5328146-2024114906-337740822147-508-607384961
0500350000000001124768501320202356432-1-47
000.010.010.040.010.01-00.010.030.090.050.09-0.080.010.17-0.040.190.131.140.051.340.69-0.34-0.05-0.91-0.310.41
00139000000-888-22-24-2226-31-40127247-90317-108-461-104-205-502-308
00000000000-1-1-1-1-2-12-15-18-20-22-34-42-510-129-192-191
130527-276016243-1766-754477-51171-7857534-9-321-200616-395-31737
0.64-0.36-10.56-4.160.24-6.931.160.5911.846.1210.4-8.495.2418.743.9456.4262.5369.7877.65122.02172.17159.39179.45252.78681,005.1476467.9
0000000000000000000000000000

Eurofins Scientific stock margins

The Eurofins Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eurofins Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eurofins Scientific.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Eurofins Scientific's sales revenue. A higher gross margin percentage indicates that the Eurofins Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Eurofins Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Eurofins Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eurofins Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eurofins Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eurofins Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Eurofins Scientific Margin History

Eurofins Scientific Gross marginEurofins Scientific Profit marginEurofins Scientific EBIT marginEurofins Scientific Profit margin
2028e20.93 %14.01 %10.59 %
2027e20.93 %14.38 %10.18 %
2026e20.93 %14.42 %9.35 %
2025e20.93 %13.92 %8.89 %
2024e20.93 %13.08 %8.42 %
202320.93 %12.92 %3.94 %
202222.54 %15.45 %8.65 %
202128.31 %21.92 %11.14 %
202025.97 %18.82 %9.29 %
201920.4 %12.57 %3.19 %
201819.04 %13.77 %4.64 %
201718.74 %13.45 %6.04 %
201618.91 %14.1 %5.46 %
201518.5 %13.55 %2.89 %
201418.47 %13.46 %5.53 %
201317.89 %13.21 %4.34 %
201216.91 %12.56 %5.15 %
201118.29 %13.2 %5.29 %
201062.73 %9.27 %3.44 %
200960.83 %6.49 %-1.76 %
200860.24 %7.6 %2.8 %
200760.53 %7.94 %3.59 %
200660.91 %10.35 %4.73 %
200564.62 %12.76 %5.3 %
200464.68 %8.52 %4.46 %

Eurofins Scientific Stock Sales Revenue, EBIT, Earnings per Share

The Eurofins Scientific earnings per share therefore indicates how much revenue Eurofins Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eurofins Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eurofins Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eurofins Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eurofins Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eurofins Scientific Revenue, EBIT and net profit per share

DateEurofins Scientific Sales per ShareEurofins Scientific EBIT per shareEurofins Scientific Earnings per Share
2028e52.5 undefined0 undefined5.56 undefined
2027e47.16 undefined0 undefined4.8 undefined
2026e42.32 undefined0 undefined3.96 undefined
2025e39.47 undefined0 undefined3.51 undefined
2024e36.83 undefined0 undefined3.1 undefined
202332.92 undefined4.25 undefined1.3 undefined
202233.73 undefined5.21 undefined2.92 undefined
202133.49 undefined7.34 undefined3.73 undefined
202027.76 undefined5.23 undefined2.58 undefined
201924.53 undefined3.08 undefined0.78 undefined
201820.66 undefined2.85 undefined0.96 undefined
201716.51 undefined2.22 undefined1 undefined
201614.96 undefined2.11 undefined0.82 undefined
201511.99 undefined1.63 undefined0.35 undefined
20148.78 undefined1.18 undefined0.49 undefined
20137.66 undefined1.01 undefined0.33 undefined
20126.6 undefined0.83 undefined0.34 undefined
20115.29 undefined0.7 undefined0.28 undefined
20104.58 undefined0.42 undefined0.16 undefined
20094.51 undefined0.29 undefined-0.08 undefined
20084.17 undefined0.32 undefined0.12 undefined
20073.26 undefined0.26 undefined0.12 undefined
20062.48 undefined0.26 undefined0.12 undefined
20051.62 undefined0.21 undefined0.09 undefined
20041.25 undefined0.11 undefined0.06 undefined

Eurofins Scientific business model

Eurofins Scientific SE is a leading group of laboratories specializing in providing testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. The company was founded in 1987 by Dr. Gilles Martin and is headquartered in Luxembourg. It has since become one of the largest laboratory service providers worldwide. Eurofins' business model is based on a wide range of analytical services that enable customers to monitor product quality, process safety, and regulatory compliance. Eurofins offers a comprehensive range of tests, including food and feed testing, residue analysis, hygiene and contamination analysis, environmental analysis, and genetic testing. The group operates more than 800 laboratories in 47 countries and employs more than 50,000 people. Eurofins has a strong presence in Europe, North America, and the Asia-Pacific region, and is active in various industries such as agriculture and food, environment and pharmaceuticals, as well as clinical diagnostics and forensics. The different divisions of Eurofins are tailored to the specific needs of its customers. For example, the "Food Testing" division offers a wide range of tests to ensure that food is safe and healthy. Thanks to these tests, manufacturers can ensure that their products comply with legal requirements and meet customer needs. Another division of Eurofins is "Environment Testing," which offers tests and analyses for a variety of environmental samples. These enable companies to monitor compliance with environmental regulations, identify environmental issues, and improve their environmental footprint. Eurofins' Biopharma division offers a variety of testing services for the biopharmaceutical industry, including clearance studies, cleaning validation, particle measurements, and DNA sequencing. In the field of clinical diagnostics, Eurofins provides laboratory services to improve diagnoses and treatments. These include genetic testing, oncology tests, prenatal diagnostics, and infectious diseases. Another important business area for Eurofins is forensics, which benefits from the latest developments in DNA analysis as well as analysis methods for detecting drugs, alcohol, and toxic substances. The services provided by Eurofins include forensic wildlife investigations and the identification of human and animal species based on DNA samples. In addition to the aforementioned business areas, Eurofins also offers a wide range of services such as consulting, audits, and training to help improve its customers' performance and help them achieve their business goals. In conclusion, Eurofins Scientific SE is a leading provider of testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. With its specialized services, the company enables its customers to monitor product quality, process safety, and regulatory compliance. Eurofins' various divisions offer tests and analyses for a variety of industries, contributing to improving its customers' businesses. Eurofins Scientific is one of the most popular companies on Eulerpool.com.

Eurofins Scientific SWOT Analysis

Strengths

Eurofins Scientific SE is recognized as an innovative market leader in the field of bio-analytical testing services. The company has a strong track record of developing cutting-edge technologies and solutions, providing them with a competitive advantage over their peers.

Eurofins operates a vast network of laboratories and offices across the globe, allowing them to serve a wide range of customers in various industries. This extensive global presence enables them to tap into diverse markets and leverage economies of scale.

Weaknesses

Eurofins relies on external suppliers for certain key materials and technologies. This dependence may pose challenges in terms of cost, quality control, and supply chain management. Any disruptions in the supply chain could negatively impact the company's operations.

Eurofins Scientific SE operates in a complex industry with diverse testing requirements and regulatory frameworks. Managing this level of complexity requires a high degree of expertise and resources. Any lapses in operational efficiency may result in delays and increased costs.

Opportunities

The global demand for bio-analytical testing services is expected to grow in the coming years due to factors such as increased regulatory requirements, rising consumer awareness, and advancements in technology. Eurofins can capitalize on this trend by expanding its service offerings and geographic reach.

Eurofins has the opportunity to expand its presence in emerging markets where demand for testing services is projected to experience significant growth. By establishing strategic partnerships and investing in infrastructure, the company can gain a strong foothold in these promising markets.

Threats

The bio-analytical testing services industry is highly competitive, with several global and local players vying for market share. Eurofins faces the threat of aggressive pricing strategies, technological advancements by competitors, and the potential entry of new disruptive players.

Eurofins operates in a regulatory environment that is subject to frequent changes and stringent standards. Compliance with evolving regulations and maintaining necessary accreditations can be demanding and time-consuming, potentially impacting the company's ability to deliver timely and cost-effective services.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Eurofins Scientific Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Eurofins Scientific historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Eurofins Scientific shares outstanding

The number of shares was Eurofins Scientific in 2023 — This indicates how many shares 197.9 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eurofins Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eurofins Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eurofins Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eurofins Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eurofins Scientific stock splits

In Eurofins Scientific's history, there have been no stock splits.

Eurofins Scientific dividend history and estimates

In 2023, Eurofins Scientific paid a dividend amounting to 1 EUR. Dividend means that Eurofins Scientific distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Eurofins Scientific provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Eurofins Scientific’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Eurofins Scientific's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Eurofins Scientific Dividend History

DateEurofins Scientific Dividend
2028e1.09 undefined
2027e1.09 undefined
2026e1.09 undefined
2025e1.09 undefined
2024e1.09 undefined
20231 undefined
20221 undefined
20210.68 undefined
20190.29 undefined
20180.24 undefined
20170.2 undefined
20160.15 undefined
20150.13 undefined
20140.12 undefined
20130.1 undefined
20120.08 undefined
20110.02 undefined
20100.01 undefined
20090.01 undefined
20080.01 undefined
20070.01 undefined

Eurofins Scientific dividend payout ratio

In 2023, Eurofins Scientific had a payout ratio of 27.48%. The payout ratio indicates the percentage of the company's profits that Eurofins Scientific distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Eurofins Scientific represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Eurofins Scientific could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Eurofins Scientific's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Eurofins Scientific Payout Ratio History

DateEurofins Scientific Payout ratio
2028e28.48 %
2027e28.03 %
2026e27.89 %
2025e29.51 %
2024e26.69 %
202327.48 %
202234.36 %
202118.23 %
202029.84 %
201936.92 %
201825.26 %
201720.2 %
201617.9 %
201538.82 %
201425 %
201330.3 %
201223.53 %
20117.41 %
20106.25 %
2009-12.5 %
20088.33 %
20078.33 %
200629.84 %
200529.84 %
200429.84 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Eurofins Scientific.

Eurofins Scientific latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241.33 1.13  (-15.24 %)2024 Q2
12/31/20231.33 1.56  (17.6 %)2023 Q4
6/30/20231.23 1.31  (6.75 %)2023 Q2
12/31/20221.5 1.46  (-2.98 %)2022 Q4
1

Eulerpool ESG Scorecard© for the Eurofins Scientific stock

Eulerpool World ESG Rating (EESG©)

95/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

87

Environment

Scope 1 - Direct Emissions
63,565
Scope 2 - Indirect emissions from purchased energy
143,696
Scope 3 - Indirect emissions within the value chain
318,356
Total CO₂ emissions
207,261
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees55
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Eurofins Scientific shareholders

%
Name
Stocks
Change
Date
32.99666 % Gilles Martin Family63,145,48007/25/2024
3.62995 % Capital Research Global Investors6,946,608-208,2259/30/2024
2.82841 % Harris Associates L.P.5,412,713-4,2008/31/2024
2.02432 % The Vanguard Group, Inc.3,873,91913,9649/30/2024
1.80892 % Mawer Investment Management Ltd.3,461,718-7,1917/31/2024
1.59609 % Norges Bank Investment Management (NBIM)3,054,426320,7306/30/2024
1.45137 % Allianz Global Investors GmbH2,777,475-4,0219/30/2024
1.42515 % RBC Global Asset Management (UK) Limited2,727,295-13,5539/30/2024
1.41127 % BlackRock Institutional Trust Company, N.A.2,700,73912,5859/30/2024
1.29862 % Ruane, Cunniff & Goldfarb L.P.2,485,15506/30/2024
1
2
3
4
5
...
10

Eurofins Scientific Executives and Management Board

Dr. Gilles Martin(60)
Eurofins Scientific Chairman of the Board, Chief Executive Officer
Compensation 1.28 M
Mrs. Valerie Hanote(57)
Eurofins Scientific Executive Director
Compensation 362,692
Mr. Pascal Rakovsky(64)
Eurofins Scientific Lead Non-Executive Independent Director
Compensation 85,000
Ms. Patrizia Luchetta(59)
Eurofins Scientific Non-Executive Independent Director
Compensation 65,000
Ms. Evie Roos(56)
Eurofins Scientific Non-Executive Independent Director
Compensation 56,667
1
2

Most common questions regarding Eurofins Scientific

What values and corporate philosophy does Eurofins Scientific represent?

Eurofins Scientific SE is a leading global provider of bioanalytical testing services. The company's values revolve around providing high-quality and reliable results to its clients. Eurofins Scientific SE follows a customer-centric approach and aims to deliver tailored solutions that meet the unique needs of its customers. The company is committed to scientific excellence, innovation, and sustainability. Eurofins Scientific SE also strives for continuous improvement, ensuring that it stays at the forefront of the industry. With a strong dedication to quality, integrity, and customer satisfaction, Eurofins Scientific SE is a trusted partner for businesses across various sectors.

In which countries and regions is Eurofins Scientific primarily present?

Eurofins Scientific SE is primarily present in numerous countries and regions worldwide. Some of the key locations where the company operates include Europe, North America, Asia-Pacific, Latin America, and Africa. Eurofins has established a strong presence in several European countries such as France, Germany, and the United Kingdom. Additionally, it has expanded its operations across the United States, Canada, China, India, and Brazil, among other countries. With its global footprint, Eurofins Scientific SE ensures a wide geographical coverage to cater to the diverse needs of its customers and clients around the world.

What significant milestones has the company Eurofins Scientific achieved?

Over the years, Eurofins Scientific SE has achieved several significant milestones. One notable achievement was the company's expansion and acquisition strategy, which helped Eurofins become a leading player in the field of bioanalytical testing services. Additionally, Eurofins Scientific SE received international recognition for its groundbreaking innovations in the areas of food and environment testing. The company's commitment to providing high-quality analytical services and its pursuit of technological advancements have positioned Eurofins as a trusted partner for industries worldwide. Through its continual dedication to excellence, Eurofins Scientific SE has established itself as a prominent global player in the scientific testing and laboratory services industry.

What is the history and background of the company Eurofins Scientific?

Eurofins Scientific SE is a leading global provider of bioanalytical testing services. Established in 1987, Eurofins has evolved into a renowned company specializing in scientific testing, with a broad range of services to support various industries such as food, environmental, pharmaceutical, and cosmetics. With more than 800 laboratories spread across 50 countries, Eurofins offers a comprehensive portfolio of testing methods to ensure safety, quality, and compliance. The company's commitment to innovation, accuracy, and customer satisfaction has earned Eurofins a reputable status in the industry. Eurofins Scientific SE continues to expand its expertise, enhance its capabilities, and provide reliable testing solutions to a diverse range of clients worldwide.

Who are the main competitors of Eurofins Scientific in the market?

The main competitors of Eurofins Scientific SE in the market are SGS SA, Bureau Veritas SA, and Intertek Group plc.

In which industries is Eurofins Scientific primarily active?

Eurofins Scientific SE is primarily active in the scientific testing and laboratory services industry. They specialize in providing a wide range of analytical services to various sectors, including food and beverage, pharmaceuticals, environment, biotechnology, and agriscience. With a strong focus on quality and accuracy, Eurofins offers solutions for assessing the safety, quality, and authenticity of products and materials. As a global leader in laboratory testing, Eurofins serves as a trusted partner for businesses, regulatory authorities, and research organizations worldwide.

What is the business model of Eurofins Scientific?

The business model of Eurofins Scientific SE revolves around providing a comprehensive range of laboratory testing services to various industries worldwide. Eurofins Scientific SE offers a wide array of services, including testing and analysis of food, environment, pharmaceuticals, cosmetics, and other materials. With a vast network of laboratories and expertise in different domains, Eurofins Scientific SE caters to the specific needs of its clients, ensuring the highest quality standards are met. By leveraging advanced technology and a strong commitment to innovation, Eurofins Scientific SE positions itself as a leading player in the global testing and scientific services industry, delivering reliable and efficient solutions to its customers.

What is the P/E ratio of Eurofins Scientific 2024?

The Eurofins Scientific P/E ratio is 15.14.

What is the P/S ratio of Eurofins Scientific 2024?

The Eurofins Scientific P/S ratio is 1.28.

What is the Quality Investing of Eurofins Scientific?

The Quality Investing for Eurofins Scientific is 7/10.

What is the revenue of Eurofins Scientific 2024?

The expected Eurofins Scientific revenue is 7.05 B EUR.

How high is the profit of Eurofins Scientific 2024?

The expected Eurofins Scientific profit is 593.79 M EUR.

What is the business model of Eurofins Scientific

Eurofins Scientific SE is a global company specializing in laboratory services for the analysis of food, environmental samples, and pharmaceutical products. Its business model is based on comprehensive services offered to customers in various sectors. The company operates a wide range of analysis and testing laboratories to ensure products are safe, effective, and compliant with national and international regulations. Eurofins primarily provides services in the field of food safety, testing a variety of foods to confirm their safety. It also offers environmental and water analysis to determine the quality of surface water, drinking water, wastewater, and soil, as well as to assess environmental pollution. Additionally, Eurofins specializes in the analysis of pharmaceutical products to ensure their safety and compliance with international regulations. In addition to these main areas, Eurofins operates laboratories for agriculture, animal health monitoring, and supporting services such as clinical diagnostics and DNA analysis technology. The company continuously invests in research and development of new technologies and methods to improve its services and provide innovative solutions to customer challenges. Overall, Eurofins Scientific SE offers a comprehensive range of laboratory services, specializing in the analysis of food, environmental samples, and pharmaceutical products. It operates multiple laboratories worldwide and strives to provide innovative and effective solutions to customer challenges.

What is the Eurofins Scientific dividend?

Eurofins Scientific pays a dividend of 1 EUR distributed over 1 payouts per year.

How often does Eurofins Scientific pay dividends?

Eurofins Scientific pays out a dividend 1 times a year.

What is the Eurofins Scientific ISIN?

The ISIN of Eurofins Scientific is FR0014000MR3.

What is the Eurofins Scientific WKN?

The WKN of Eurofins Scientific is A2QJCT.

What is the Eurofins Scientific ticker?

The ticker of Eurofins Scientific is ERF.PA.

How much dividend does Eurofins Scientific pay?

Over the past 12 months, Eurofins Scientific paid a dividend of 1 EUR . This corresponds to a dividend yield of about 2.2 %. For the coming 12 months, Eurofins Scientific is expected to pay a dividend of 1.09 EUR.

What is the dividend yield of Eurofins Scientific?

The current dividend yield of Eurofins Scientific is 2.2 %.

When does Eurofins Scientific pay dividends?

Eurofins Scientific pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Eurofins Scientific?

Eurofins Scientific paid dividends every year for the past 8 years.

What is the dividend of Eurofins Scientific?

For the upcoming 12 months, dividends amounting to 1.09 EUR are expected. This corresponds to a dividend yield of 2.39 %.

In which sector is Eurofins Scientific located?

Eurofins Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurofins Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurofins Scientific from 7/5/2024 amounting to 0.5 EUR, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Eurofins Scientific pay the last dividend?

The last dividend was paid out on 7/5/2024.

What was the dividend of Eurofins Scientific in the year 2023?

In the year 2023, Eurofins Scientific distributed 1 EUR as dividends.

In which currency does Eurofins Scientific pay out the dividend?

The dividends of Eurofins Scientific are distributed in EUR.

All fundamentals about Eurofins Scientific

Our stock analysis for Eurofins Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurofins Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.